These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 15887955

  • 21. Varenicline.
    Kassem MG, Al Hossaini AM.
    Profiles Drug Subst Excip Relat Methodol; 2012; 37():389-411. PubMed ID: 22469324
    [No Abstract] [Full Text] [Related]

  • 22. 7-Azaindole derivatives as potential partial nicotinic agonists.
    Stoit AR, den Hartog AP, Mons H, van Schaik S, Barkhuijsen N, Stroomer C, Coolen HK, Reinders JH, Adolfs TJ, van der Neut M, Keizer H, Kruse CG.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):188-93. PubMed ID: 18006307
    [Abstract] [Full Text] [Related]

  • 23. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL, Trocmé-Thibierge C, Guendisch D, Al Rubaiy SA, Bloom SA.
    J Pharmacol Exp Ther; 2011 May 01; 337(2):367-79. PubMed ID: 21285282
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2011 May 01; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
    Eaton MJ, Ospina CA, Rodríguez AD, Eterović VA.
    Neurosci Lett; 2004 Aug 05; 366(1):97-102. PubMed ID: 15265598
    [Abstract] [Full Text] [Related]

  • 33. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD, Surowy CS.
    Mol Pharmacol; 2006 Jul 05; 70(1):227-40. PubMed ID: 16569710
    [Abstract] [Full Text] [Related]

  • 34. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
    Zaniewska M, McCreary AC, Stefański R, Przegaliński E, Filip M.
    Synapse; 2008 Dec 05; 62(12):935-9. PubMed ID: 18798299
    [Abstract] [Full Text] [Related]

  • 35. [Varenicline--a new chance for smokers?].
    Goniewicz ML, Koszowski B, Czogała J, Sobczak A.
    Przegl Lek; 2007 Dec 05; 64(10):899-902. PubMed ID: 18409337
    [Abstract] [Full Text] [Related]

  • 36. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM, Stevens KE.
    Pharmacol Biochem Behav; 2011 Nov 05; 100(1):17-24. PubMed ID: 21763340
    [Abstract] [Full Text] [Related]

  • 37. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T, Hrachova M, Chin M, McIntosh JM, Quik M.
    J Pharmacol Exp Ther; 2012 Aug 05; 342(2):327-34. PubMed ID: 22550286
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP, Jensen AA, Christensen JK, Balle T, Liljefors T, Frølund B.
    J Med Chem; 2008 Dec 11; 51(23):7380-95. PubMed ID: 18989912
    [Abstract] [Full Text] [Related]

  • 40. 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
    Coe JW, Brooks PR, Wirtz MC, Bashore CG, Bianco KE, Vetelino MG, Arnold EP, Lebel LA, Fox CB, Tingley FD, Schulz DW, Davis TI, Sands SB, Mansbach RS, Rollema H, O'Neill BT.
    Bioorg Med Chem Lett; 2005 Nov 15; 15(22):4889-97. PubMed ID: 16171993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.